DoW Neurofibromatosis Synergistic Idea Award
The summary for the DoW Neurofibromatosis Synergistic Idea Award grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Defense Health Agency Contracting Activity - DHACA, which is the U.S. government agency offering this grant.
DoW Neurofibromatosis Synergistic Idea Award: Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Synergistic Idea Award (SIA) supports new ideas that represent synergistic approaches to neurofibromatosis (NF) research involving two or three Principal Investigators (PIs). These investigators should utilize their complementary and synergistic perspectives to address a central problem or question in NF research. Applications must include preliminary and/or published data that are relevant to NF and the proposed research project.Distinctive Features:• Partnering Principal Investigators: One PI will be identified as the Initiating PI and will be responsible for the majority of the administrative tasks associated with application submission. An additional one or two PI(s) will be identified as a Partnering PI. Each partner will be recognized as a PI, submit a separate application (even if the partners are at the same organization), and receive an individual award.
| Federal Grant Title: | DoW Neurofibromatosis Synergistic Idea Award |
| Federal Agency Name: | Defense Health Agency Contracting Activity - DHACA (DOD-AMRAA) |
| Grant Categories: | Science and Technology and other Research and Development |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | HT942526NFRPSIA |
| Type of Funding: | Grant |
| CFDA Numbers: | 12.420 |
| CFDA Descriptions: | Information not provided |
| Current Application Deadline: | September 22nd, 2026 |
| Original Application Deadline: | September 22nd, 2026 |
| Posted Date: | June 25th, 2026 |
| Creation Date: | June 25th, 2026 |
| Archive Date: | October 22nd, 2026 |
| Total Program Funding: | $6,400,000 |
| Maximum Federal Grant Award: | |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | 2 |
| Cost Sharing or Matching: | No |
| Last Updated: | June 25th, 2026 |
- Applicants Eligible for this Grant
- Unrestricted (i.e., open to any type of entity below), subject to any clarification in text field entitled "Additional Information on Eligibility"
- Grant Announcement Contact
- eBRAP Help Desk
Phone: 301-682-5507
Email: [email protected]
eBRAP Help Desk - Similar Government Grants
- • DoW Neurofibromatosis Exploration-Hypothesis Development Award
- • DoW Neurofibromatosis Research Academy - Scholar Award
- • DoW Neurofibromatosis Investigator-Initiated Research Award
- • DOW Combat Readiness - Medical Research Program Translational Research Award
- • DoW Neurofibromatosis Research Academy - Leadership Award
- • FY2006 Deployed War Fighter Protection Research Program
- • Department of Defense (DOD) Fiscal Year 2003 (FY03) Breast Cancer Research Program (BCRP)C...
- • Department of Defense (DOD) Fiscal Year 2004 (FY04) Breast Cancer Research Program (BCRP) ...
- More Grants from the Defense Health Agency Contracting Activity - DHACA
- • DoW Neurofibromatosis Exploration-Hypothesis Development Award
- • DoW Neurofibromatosis Research Academy - Scholar Award
- • DoW Neurofibromatosis Investigator-Initiated Research Award
